Relationship of CD4 + T-cell counts and plasma HIV-1 RNA levels with serological HBeAg/anti-HBe patterns obtained in West-African HBV-HIV-1-co-infected children

Journal of Tropical Pediatrics

Volumn 55, Issue 6, 2009, Pages 409-412

  Rouet, François ^a   Chaix, Marie Laure ^b   Kpozehouen, Alphonse ^c   Inwoley, André ^a   Anaky, Marie France ^d   Fassinou, Patricia ^e   Rouzioux, Christine ^b   Blanche, Stéphane ^b   Msellati, Philippe ^f  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CENTRE MURAZ   (Burkina Faso)

^d PACCI   (Côte d’Ivoire)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^f AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Africa; Children; HBV; HIV

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA; VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; OUTCOME ASSESSMENT; SEROLOGY; VIRUS REPLICATION;

EID: 73049094259     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmp034     Document Type: Article

References (9)

1. Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 2007;7:402-9.
2. Thio CL. Diagnosis, diagnostic tests and monitoring of hepatitis B virus in monoinfected and HIV-coinfected patients. Antiviral Ther 2007;12:H25-31.
3. Puoti M, Torti C, Bruno R, et al. Natural history of chronic hepatitis B in co-infected patients. J Hepatol 2006;44:S65-70.
4. Rouet F, Fassinou P, Inwoley A, et al. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens. AIDS 2006;20:2315-9.
5. Rouet F, Chaix ML, Inwoley A, et al. Frequent occurrence of chronic hepatitis B virus infection among west African HIV type-1 infected children. Clin Infect Dis 2008;46:361-6.
6. Brown H, Prescott R. Applied Mixed Models in Medical. New York, NY: John Willey and Sons, Inc, 2001.
7. Rouet F, Chaix ML, Inwoley A, et al. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study. J Med Virol 2004;74:34-40.
8. Chamorro AJ, Casado JL, Bellido D, et al. Reactivation of hepatitis B in an HIV-infected patient with antibodies against hepatitis B core antigen as the only serological marker. Eur J Clin Microbiol Infect Dis 2005;24:492-4.
9. Chang JJ, Wightman F, Bartholomeusz A, et al. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J Virol 2005;79:3038-51.